Xvivo Perfusion: Preview Q3
Research Note
2020-10-20
15:00
Redeye: Xvivo is scheduled to release its Q3 earnings results on 23 October before the stock market opens. Following the release, the company will host a telephone conference at 2:30 p.m. CET. We have earlier penciled in a significant impact from the coronavirus outbreak in Q3 as we recognize that the effects would continue for the rest of the year, with the second and third quarters to be most affected. The visibility continues to be limited, and the impact of a second wave is hard to estimate. The outlook and comments surrounding the rest of the year continue to be more important than the short-term effects. However, the long-term potential has improved even more due to the recent addition of Organ Assist.
MH
Mats Hyttinge
Disclosures and disclaimers